Successful Management of a Black Male With Psoriasis and Dyspigmentation Treated With Halobetasol Propionate 0.01% Tazarotene 0.045% Lotion: Case Report JDDonline Journal of Drugs in Dermatology Figure 2 from Changes of melanocytic lesions inducedby Melanotan injections and sun bed use ina teenage patient with FAMMM syndrome Semantic Scholar What is Melanotan II the drug that the TGA urges consumers to avoid? The Impact and Treatment of Psoriasis in Manitoba Dermatology Clinics: The Case for Calcipotriol Betamethasone Dipropionate Foam Formulation